Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Trenton News Today.
Press releases published on June 25, 2025
Verizon contributes $10K in response to devastating flooding in West Virginia
GlobeNewswire
·
June 25, 2025
WHEELING, W.Va., June 25, 2025 (GLOBE NEWSWIRE) -- On June 15, devastating heavy rains and flash flooding severely impacted Ohio and Marion counties in West Virginia. This rare event saw up to 3 to 4 inches of rainfall in less than an hour in localized …
Aterian Expands Presence on Mercado Libre into Chile, Colombia, and Argentina
GlobeNewswire
·
June 25, 2025
SUMMIT, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER), a consumer products company, today announced the expansion of its presence on Mercado Libre, Latin America’s leading e-commerce platform. Building on its 2024 launch on Mercado …
Hepion Pharmaceuticals Successfully Completes Application to the OTCQB
GlobeNewswire
·
June 25, 2025
MORRISTOWN, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (OTCQB:HEPA), a clinical stage biopharmaceutical company that is developing and commercializing diagnostic tests for celiac disease, respiratory multiplex (Covid/Influenza A/B …
Synchronoss Achieves EU-U.S. Data Privacy Framework Certification
GlobeNewswire
·
June 25, 2025
BRIDGEWATER, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- Synchronoss Technologies, Inc. (“Synchronoss”) (NASDAQ: SNCR), a global leader and innovator in personal cloud platforms for telecoms, today announced that it has achieved certification under the EU-U.S. …
Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
GlobeNewswire
·
June 25, 2025
RUTHERFORD, N.J. and STOCKHOLM, June 25, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced results …
Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences
GlobeNewswire
·
June 25, 2025
Amneal holds exclusive U.S. commercialization rights; BLA filing expected in Q4 2025 Poised to be among the first wave of biosimilars in the $3.9 billion U.S. omalizumab market and an important growth driver for Amneal BRIDGEWATER, N.J., June 25, 2025 ( …
Bryn Pharma Announces First Participant Dosed in PK/PD Trial with Upgraded Nasal Spray Device, Including First-of-Its-Kind, Two-Doses-in-One Nasal Spray Profile
GlobeNewswire
·
June 25, 2025
New clinical trial data with Bryn Pharma’s second-generation epinephrine nasal spray expected in Q3 2025 The trial employs an upgraded two-spray nasal spray device providing additional reliability and user experience enhancements Trial includes evaluation …
BIO-key Joins ISMS Forum to Advance Cybersecurity and Identity Management Best Practices in Spain
GlobeNewswire
·
June 25, 2025
MADRID and HOLMDEL, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication solutions, today announced that it has joined ISMS Forum, Spain’s …
ConnectOne Bancorp Strengthens Executive Leadership By Appointing Legal Advisor Robert Schwartz to General Counsel
GlobeNewswire
·
June 25, 2025
ENGLEWOOD CLIFFS, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the "Company" or "ConnectOne"), parent company of ConnectOne Bank (the "Bank"), announced the appointment of Robert A. Schwartz as General Counsel, effective …
Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit
GlobeNewswire
·
June 25, 2025
WARREN, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and …
Amicus Therapeutics Announces Approval of Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) in Japan
GlobeNewswire
·
June 25, 2025
PRINCETON, N.J., and TOKYO, June 25, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Pombiliti (cipaglucosidase alfa) + Opfolda (miglustat) for the …
Haal meer uit de cloud met expertise van AWS en een MSP
GlobeNewswire
·
June 25, 2025
Amsterdam, Nederland, Juni 2025, Sean Tilley, Director of Sales EMEA bij 11:11 Systems, een provider van beheerde infrastructuuroplossingen, gaat dieper in op de basisinformatie van data voor de moderne onderneming en hoe die bedrijven in staat stelt te …
Transformez le cloud en levier de succès en alliant AWS à l’expertise des MSP
GlobeNewswire
·
June 25, 2025
Paris, France, juin 2025, Sean Tilley, directeur commercial senior chez 11:11 Systems, un MSP reconnu, examine le rôle essentiel des données dans l’entreprise moderne et leur importance pour son fonctionnement. Alors que la complexité et la richesse de l’ …
Verizon Business wins multisite private 5G contract fueling a multibillion dollar regeneration project
GlobeNewswire
·
June 25, 2025
What you need to know: Verizon Business, in collaboration with Nokia, will deliver multiple Verizon Private 5G Networks to industrial campuses across the Thames Freeport, one of the UK’s busiest maritime logistics and manufacturing regions. The Thames …